top of page
gradientForSurfBreak.png

Item List

Yahoo Finance
Compelling Clinical Data Released for Carlsmed’s aprevo® Technology

Carlsmed announced today that new clinical data on its aprevo® technology has been published in the Global Spine Journal. This landmark study of a patient-matched cohort concluded that the use of aprevo® personalized interbody devices enables a significant improvement in achieving alignment. The study measured the difference in pelvic incidence (PI) and lumbar lordosis (LL), referred to as PI-LL mismatch, comparing personalized spine surgery and traditional spine surgery. Prior studies have shown that achieving optimal alignment during spine fusion surgery is highly correlated with reduced complications.

Recent Posts

Portfolio Company

Carlsmed.png

Citizen Health Announces $14.5 Million Seed Funding and Partnerships to Transfor ...

Chan Zuckerberg Initiative

Portfolio Company

Carlsmed.png

xCures Unveils Next-Generation AI-Powered Data Platform ...

Engineering

Portfolio Company

Carlsmed.png

Gradient Health announces acquisition of DataAppraisal to accelerate medical AI ...

HealthCare Business

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page